Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
4
×
national blog main
4
×
boston blog main
national top stories
startups
texas blog main
texas top stories
australia
biotech
boston
clinical trials
drugs
houston
innovation
life sciences
medical devices
medtech
people
texas
texas medical center
united kingdom
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
ancor capital partners
andrew berens
anirvan ghosh
astrazeneca
avapritinib
bill mckeon
biobridge
biogen
blueprint medicines
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
What
announced
4
×
center
innovation
medical
new
plans
roundup
texas
acquisitions
approval
bio
biobridge
blueprint
cancer
catch
center’s
ceo
chasing
collabs
covid
daniel
deadly
deal
deciphera
director
drug
execs
expansion
fannin
fda
filing
forms
gi
gilead
gilead’s
head
help
houston
institute
introduce
Language
unset
Current search:
announced
×
cancer
×
" national blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
TX Roundup: TMC’s BioBridge to the UK, New Execs at Fannin & TechFW